Drone Guarder, Inc. (OTC Pink: DRNG) is engaged as a drone-based security system provider. Shares of the security company are diving 33.01%, through afternoon trading on Friday, June 16, 2017. Over the past month, Drone Guarder, Inc. has seen average daily volume of 306,253 shares on the day. However, volume of 180,358 shares or dollar volume of $47,975, has already exchanged hands on Friday.
Shares of Drone Guarder, Inc. are under pressure on Friday, after the company announced that it has been notified by OTC Markets, regarding promotional activities. As a result, OTC Markets has done a Caveat Emptor change. Here is the full press release detailing of the Caveat Emptor change:
Drone Guarder, Inc. Press Release:
LONDON, June 14, 2017 (GLOBE NEWSWIRE) — Drone Guarder, Inc. (OTCQB:DRNG) announced today that OTC Markets Group has made the Company aware of promotional activity regarding its shares and designated a Caveat Emptor on the stock.
OTC Markets informed the Company that it became aware of certain promotional activities concerning DroneGuarder Inc. and its common stock encouraging investors to purchase shares in an enhanced manner. The Company has been informed that this promotional activity may have had a material effect on the trading activity and market for the Company’s stock. Until informed by OTC Markets, the Company was unaware of the promotional activity and remains unaware of the full nature and content of this activity, the extent of the dissemination or the parties involved. OTC Markets has designated a Caveat Emptor on the stock for a minimum of 30 days.
The Company states definitively that the Company, its officers, directors and, to the Company’s knowledge, its controlling shareholders have not, directly or indirectly, authorized or been involved in any way with the creation or distribution of promotional materials of any kind. The Company, its officers, directors and controlling shareholders have not sold or purchased the Company’s securities within the past 120 days.
“The Company has only released 3 official press releases based upon material corporate events at the company. The Company intends to provide disclosure of legitimate and ongoing corporate activity focused on the Company’s business operations. The Company has not, and will not engage in any stock promotional activities,” stated Adam Taylor, CEO of DroneGuarder, Inc. “We have been working diligently to deliver the Company’s prototype drone in early July and for final delivery of the product by November 2017.”
The Company encourages those interested in the Company to rely solely on information included in its press releases combined with its filings and disclosures made with the Securities and Exchange Commission.
About Drone Guarder, Inc.
Drone Guarder, Inc. is an early stage security and surveillance company focusing on commercializing a drone enhanced home security system as a turnkey solution. The solution is app-based and includes a drone, infrared camera, and Android mobile app component: Once an alarm has been triggered, the DroneGuarder™ will immediately take off from a wireless charging pad.
Please visit http://www.droneguarder.com to learn about the company, management, and products.
This press release may contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such statements include, but are not limited to, any statements relating to our growth strategy and product development programs and any other statements that are not historical facts. Forward-looking statements are based on management’s current expectations and are subject to risks and uncertainties that could negatively affect our business, operating results, financial condition and stock price. Factors that could cause actual results to differ materially from those currently anticipated are: risks related to our growth strategy; risks relating to the results of research and development activities; our ability to obtain, perform under and maintain financing and strategic agreements and relationships; uncertainties relating to preclinical and clinical testing; our dependence on third-party suppliers; our ability to attract, integrate, and retain key personnel; the early stage of products under development; our need for substantial additional funds; government regulation; patent and intellectual property matters; competition; as well as other risks described in our SEC filings. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations or any changes in events, conditions or circumstances on which any such statement is based, except as required by law.